Heron Therapeutics
HRTX
#8027
Rank
$0.19 B
Marketcap
$1.28
Share price
-30.43%
Change (1 day)
132.73%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2024 (TTM): $0.13 Billion USD

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.13 Billion USD. In 2023 the company made a revenue of $0.12 Billion USD an increase over the revenue in the year 2022 that were of $0.10 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.13 B7.33%
2023 $0.12 B17.99%
2022 $0.10 B24.7%
2021 $86.34 M-2.59%
2020 $88.63 M-39.28%
2019 $0.14 B88.41%
2018 $77.47 M151.81%
2017 $30.76 M2305.55%
2016 $1.27 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 $0.64 M-50.35%
2010 $1.3 M3.17%
2009 $1.26 M240.81%
2008 $0.37 M
2005 $5.39 M-0.24%
2004 $5.4 M11.45%
2003 $4.84 M-12.31%
2002 $5.53 M26.05%
2001 $4.38 M30.35%
2000 $3.36 M-84.09%
1999 $21.16 M6.88%
1998 $19.8 M8.79%
1997 $18.2 M-3.19%
1996 $18.8 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$1.50 B 1,003.78%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.69 B 406.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$93.15 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.13 B-2.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.12 B-11.40%๐Ÿ‡บ๐Ÿ‡ธ USA